The role of DNA polymerase eta in DNA damage response and p53 activation
The role of DNA polymerase eta in DNA damage response and p53 activation
批准号:
8035416
负责人:
Xinbin Chen
金额:
$27.77万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2015-01-31
关键词:
AddressApoptosisBypassCarcinogensCell DeathCell SurvivalCellsDNA DamageDNA biosynthesisDNA lesionDNA-Directed DNA PolymeraseDegradation PathwayDevelopmentDiseaseDouble Strand Break RepairExhibitsFamilyFrequenciesGene TargetingGenesGenomic InstabilityLeadLesionMalignant - descriptorMalignant NeoplasmsModificationMono-SNucleotide Excision RepairNull LymphocytesPathway interactionsPatientsPlayProtein p53ProteinsPyrimidine DimersRad30 proteinRoleSignal PathwaySister Chromatid ExchangeSkin CancerTP53 geneTreatment EfficacyTumor Suppressor ProteinsUV inducedUbiquitinationVariantXeroderma Pigmentosumearly onsethomologous recombinationnovelpreventpublic health relevancereconstitutionrepairedresponsetumor initiationtumor progressionubiquitin-protein ligaseultraviolet irradiation
中文摘要
描述(由申请人提供):DNA聚合酶eta在DNA损伤反应和p53激活中的作用。本申请旨在研究DNA聚合酶eta (PolH)在DNA损伤反应和p53激活中的信号通路,以及p53与PolH信号通路相互作用对细胞生存和死亡的影响。为了描述p53在DNA损伤反应中的作用,我们发现DNA损伤可以以p53依赖的方式诱导PolH。PolH是色素干皮病(XP)基因的产物。XP是一种常染色体隐性遗传病,XP患者易发生恶性皮肤癌的早发性。有趣的是,我们发现敲低PolH通过抑制DNA损伤诱导的细胞凋亡来提高细胞存活率。我们还发现,DNA损伤诱导的p53激活在PolH-敲低和PolH-缺失的细胞中都受到损害,这可以通过重组的PolH来挽救。此外,我们发现PolH通过ATM- ChK2-p53通路调节DNA损伤反应。最后,我们最近的初步研究表明,当DNA损伤时,PolH蛋白的稳定性降低,PolH与Mdm2和Pirh2物理相互作用,两者都是p53的靶基因和E3连接酶。综上所述,我们假设PolH活性受多种途径调控,PolH在DNA损伤反应和p53激活中具有新的功能。为了进一步解决这一问题,提出了以下三个具体目标:(1)确定PolH表达是否以及如何在基础和DNA损伤条件下受到调节;(2)确定PolH与Mdm2或Pirh2相互作用的功能意义;(3)确定PolH在DNA损伤反应和p53激活中的作用。
英文摘要
DESCRIPTION (provided by applicant): The role of DNA polymerase eta in DNA damage response and p53 activation. This application is proposed to address the signaling pathway of DNA polymerase eta (PolH) in DNA damage response and p53 activation and the effect of the signal pathway interaction between p53 and PolH on cell survival and death. In an effort to characterize the role of p53 in DNA damage response, we found that PolH can be induced by DNA damage in a p53-dependent manner. PolH is the product of the Xeroderma Pigmentosum (XP) gene. XP is an autosomal recessive disorder, and XP patients are prone to early onset of malignant skin cancers. Interestingly, we found that knockdown of PolH enhances cell survival by inhibiting DNA damage-induced apoptosis. We also found that DNA damage-induced activation of p53 is impaired in both PolH-knockdown and PolH-null cells, which can be rescued by a reconstituted PolH. Furthermore, we found that PolH modulates DNA damage response via the ATM- ChK2-p53 pathway. Finally, our recent preliminary studies showed that the stability of PolH protein is decreased upon DNA damage and PolH physically interacts with Mdm2 and Pirh2, both of which are a p53 target gene and an E3 ligase. Taken together, we hypothesize that PolH activity is regulated by multiple pathways and PolH has novel functions in DNA damage response and p53 activation. To further address this, the following three specific aims are proposed: (1) to determine whether and how PolH expression is regulated at basal and DNA damage conditions; (2) to determine the functional significance of the interaction between PolH and Mdm2 or Pirh2; and (3) to determine the role of PolH in DNA damage response and p53 activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53
-
批准号:10501882
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2022
-
负责人:Xinbin Chen
-
依托单位:
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53
-
批准号:10650436
-
项目类别:
-
资助金额:$43.15万
-
财政年份:2022
-
负责人:Xinbin Chen
-
依托单位:
UC Davis DVM/PhD Medical Scientist Training Program
-
批准号:10641812
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2020
-
负责人:Xinbin Chen
-
依托单位:
Mechanism of p53-dependent Tumor Suppression
-
批准号:10360506
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2020
-
负责人:Xinbin Chen
-
依托单位:
UC Davis DVM/PhD Medical Scientist Training Program
-
批准号:10204049
-
项目类别:
-
资助金额:$24.02万
-
财政年份:2020
-
负责人:Xinbin Chen
-
依托单位:
Mechanism of p53-dependent Tumor Suppression
-
批准号:10574526
-
项目类别:
-
资助金额:$44.46万
-
财政年份:2020
-
负责人:Xinbin Chen
-
依托单位:
The feedback loop between ferredoxin reductase and the p53 family in tumor suppression
-
批准号:10330451
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2018
-
负责人:Xinbin Chen
-
依托单位:
The role of the p63-RBM38 loop in tumor suppression
-
批准号:9244740
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2016
-
负责人:Xinbin Chen
-
依托单位:
The role of the p63-RBM38 loop in tumor suppression
-
批准号:9904126
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2016
-
负责人:Xinbin Chen
-
依托单位:
The role of the p63-RBM38 loop in tumor suppression
-
批准号:9118598
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2016
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:8433258
-
项目类别:
-
资助金额:$26.22万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:8207293
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:7898966
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:8606823
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
Regulation of Mutant P53 Expression and Oncogenic Activity
-
批准号:8676449
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Molecular Oncogenic Properties of Mutant p53
-
批准号:7994858
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Regulation of Mutant P53 Expression and Oncogenic Activity
-
批准号:8520202
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Molecular Oncogenic Properties of Mutant p53
-
批准号:7391038
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Regulation of Mutant P53 Expression and Oncogenic Activity
-
批准号:8391661
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Molecular Oncogenic Properties of Mutant p53
-
批准号:7212503
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: